Endoscopic Ultrasound-guided Radio-frequency Ablation for Pancreatic Cancer
10.15279/kpba.2021.26.2.98
- Author:
Pradermchai KONGKAM
1
;
Rungsun RERKNIMITR
Author Information
1. Gastrointestinal Endoscopy Excellence Center and Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
- Publication Type:Review Article
- From:Korean Journal of Pancreas and Biliary Tract
2021;26(2):98-104
- CountryRepublic of Korea
- Language:English
-
Abstract:
Prognosis of unresectable pancreatic cancer is poor with the rate of surviving more than 5 years is less than 10% despite multi-modalities treatment. The American Society of Clinical Oncology suggested that all patients with metastatic pancreatic cancer should be offered information about clinical trials. Endoscopic ultrasound guided radio frequency ablation has been recently used in patients with advanced stage pancreatic cancer in a few studies. This article has reviewed information from published articles using endoscopic ultrasound guided radio frequency ablation for advanced pancreatic cancer.
